Your browser doesn't support javascript.
loading
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma.
Yeku, Oladapo; Russo, Andrea L; Lee, Hang; Spriggs, David.
Afiliação
  • Yeku O; Division of Hematology-Oncology, Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, USA. Oyeku@mgh.harvard.edu.
  • Russo AL; Department of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, USA.
  • Lee H; Biostatistics Center, Harvard Medical School, Massachusetts General Hospital, Boston, USA.
  • Spriggs D; Division of Hematology-Oncology, Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, USA.
J Transl Med ; 18(1): 350, 2020 09 14.
Article em En | MEDLINE | ID: mdl-32928237
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma de Células Escamosas Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma de Células Escamosas Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article